Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

81.42
-0.2760-0.34%
Post-market: 81.580.1600+0.20%19:30 EDT
Volume:241.06K
Turnover:19.60M
Market Cap:3.55B
PE:- -
High:81.75
Open:81.56
Low:81.15
Close:81.70
52wk High:85.46
52wk Low:64.30
Shares:43.55M
Float Shares:43.50M
Volume Ratio:1.06
T/O Rate:0.55%
Dividend:1.02
Dividend Rate:1.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Sep 15

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Sep 15

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Sep 15

Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares

TIPRANKS
·
Sep 15

JNJ Reports Low Rates of Treatment-Related Events for Rybrevant Faspro Plus Lazcluze at Wclc 2026

Reuters
·
Sep 15

J&J - Fewer than 1% Discontinue Rybrevant Faspro Plus Lazcluze Due to Treatment-Related Events at One Year

THOMSON REUTERS
·
Sep 15

Prescient Therapeutics Extends Securities Purchase Plan Deadline

TIPRANKS
·
Sep 15

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
Sep 15

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 15

Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline

TIPRANKS
·
Sep 15

Contineum Therapeutics Says Phase 2 Major Depressive Disorder Study Fails to Meet Primary Efficacy Endpoint

MT Newswires Live
·
Sep 15

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

TIPRANKS
·
Sep 15

Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint

Dow Jones
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Contineum, J&J's Depression Drug Fails to Meet Mid-Stage Trial Goal

Reuters
·
Sep 15

Contineum Therapeutics, - Johnson & Johnson Continues to Evaluate Trial Data for Jnj-5120/Pipe-307

THOMSON REUTERS
·
Sep 15

Merck & Co Exec Says Potential 340B and Policy Evolutions Would Create Tailwinds but are not Material to the Business - Morgan Stanley Conf

THOMSON REUTERS
·
Sep 15

Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is "to be Determined" Adds "It's Coming"

THOMSON REUTERS
·
Sep 15